FDA Clears Tumor Profiling Assay that Analyzes 425 Cancer-Related Genes
The NGS-based test joins CE-IVD and NMPA approvals for global market access.
Latest Articles
Editor's Top Picks
Clinical Labs Navigate What’s Next After FDA’s LDT Rule Reversal
Greer Massey, PhD, chief scientific officer at Molecular Designs, shares insights on how labs are affected by the rule’s reversal and how they can prepare for future regulatory changes.
Be the First to Know What’s Next in the Lab
Every week, we dig into the biggest shifts, breakthroughs, and tech transforming clinical diagnostics. Straightforward, insightful, and always relevant.Critical Resources
Diagnostic Innovations
Natera’s Signatera Test Integrated into Phase III Bladder Cancer Trial
The ARCHER study will evaluate shortened radiation therapy while using ctDNA testing to monitor treatment response and disease recurrence.
Equipment & Supply Spotlight
SmartLabs Partners with Sonrai to Integrate AI Analytics Platform
The exclusive partnership will bring Sonrai Discovery's precision medicine capabilities to SmartLabs' network of managed research centers.
News, Know-How & Standards
Disease Detection & Understanding
Host Response Testing Gains Attention in Sepsis Diagnosis and Antibiotic Stewardship
A recent poll highlights growing interest in host response testing for sepsis. Immunexpress CEO Rollie Carlson discusses the findings and the future of rapid diagnostics.
